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The impact of hypothetical PErsonalised
Risk Information on informed choice and
intention to undergo Colorectal Cancer
screening colonoscopy in Scotland (PERI
CCS)—a randomised controlled trial
Jayne Digby1*, Ronan E. O’Carroll2, Julie A. Chambers2 and Robert J. C. Steele1
Abstract
Background: There is currently no existing evidence on the effects of personalised risk information on uptake of
colonoscopy following first line screening for colorectal cancer. This study aimed to measure the impact of providing risk
information based on faecal haemoglobin concentration to allow a fully informed choice around whether or not to
undergo colonoscopy.
Methods: Two thousand seven hundred sixty-seven participants from the Scottish Bowel Screening Programme (SBoSP)
database, who had not recently been invited for screening, were randomised to receive one of three types of
hypothetical risk information materials: (1) numerical risk information (risk categories of one in 40, one in 1600 and one in
3500), (2) categorical risk information (highest, moderate and lowest risk), or (3) positive screening result letter (control
group). The primary outcome was the impact of the risk materials on intention to undergo colonoscopy, to allow
comparison with the current colonoscopy uptake of 77% for those with a positive screening result in the SBoSP.
Secondary outcomes were knowledge, attitudes and emotional responses to the materials.
Results: Four hundred thirty-four (15.7%) agreed to participate with 100 from the numerical risk group (69.0%), 104 from
the categorical risk group (72.2%) and 104 from the control group (71.7%) returning completed materials. Intention to
undergo colonoscopy was highest in the highest risk groups for the numerical and categorical study arms (96.8% and
95.3%, respectively), but even in the lowest risk groups was > 50% (58.1% and 60.7%, respectively). Adequate knowledge
of colorectal screening and the risks and benefits of colonoscopy was found in ≥ 98% of participants in all three arms. All
participants reported that they found the information easy-to-understand. 19.1%, 24.0% and 29.6% of those in the
numerical, categorical and control group, respectively, reported that they found the information distressing (p> 0.05).
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© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: jaynedigby@nhs.net
1Centre for Research into Cancer Prevention and Screening, University of
Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland,
UK
Full list of author information is available at the end of the article
Digby et al. BMC Medicine          (2020) 18:285 
https://doi.org/10.1186/s12916-020-01750-3
(Continued from previous page)
Conclusions: Applying the risk categories to existing SBoSP data shows that if all participants were offered an informed
choice to have colonoscopy, over two thirds of participants would intend to have the test. Equating to an increase in the
number of screening colonoscopies from approx. 14,000 to 400,000 per annum, this would place an unmanageable
demand on colonoscopy services, with a very small proportion of cancers and pre-cancers detected. However, the
response to the materials were very positive, suggesting that providing risk information to those in lowest and moderate
risk groups along with advice that colonoscopy is not currently recommended may be an option. Future research would
be required to examine actual uptake.
Trial registration: Date applied 1 December 2017 ISRCTN number 14254582.
Keywords: Informed choice, Personalised risk, Faecal immunochemical test, Colorectal cancer screening
Background
Following a successful demonstration pilot [1] a quantita-
tive faecal immunochemical test for haemoglobin (FIT)
was introduced as the primary test in the Scottish Bowel
Screening Programme (SBoSP) in late 2017, replacing the
guaiac faecal occult blood test (gFOBT). The advantages
of FIT over gFOBT are well accepted, including being
more user-friendly, specific for human haemoglobin, and
importantly, providing an estimation of faecal haemoglo-
bin concentration (f-Hb) rather than a binary positive/
negative result. Since f-Hb is related to severity of disease
[2], the numerical FIT result is an important risk factor
for colorectal cancer (CRC). Indeed, a recent study in a
symptomatic population referred for colonoscopy identi-
fied f-Hb as by far the most powerful predictor of all risk
factors studied including age, gender, symptoms, family
history and lifestyle factors [3]. However, in the SBoSP,
FIT is currently used as dichotomous test, with the thresh-
old for a positive result set at f-Hb of ≥ 80 μg Hb/g faeces
to mimic the 2% positivity rate observed with the previous
gFOBT-based screening algorithm. Although not as
strongly predictive as f-Hb, increasing age and male sex
have also been documented to show association with CRC
prevalence [4]. Therefore, there is potential for f-Hb, along
with age, sex and other risk factors to be used to provide a
personalised risk of harbouring CRC, and thus empower
people to make a truly informed decision about having a
colonoscopy, by weighing the risks and disadvantages of
the procedure (e.g. bleeding, bowel wall perforation, emo-
tional distress) against their personalised risk of missing a
cancer. This is particularly important in CRC screening, as
currently about half of all cancers in the screened popula-
tion in Scotland are diagnosed in the interval between
screens, indicating that, at the current threshold, the test
is only about 50% sensitive for CRC. Reducing the thresh-
old would result in fewer cancers being missed but would
increase the chance of a negative colonoscopy and the im-
pact on the colonoscopy service may be unsustainable.
There is currently no existing evidence on the effects
of personalised risk information on uptake of colonos-
copy following first line screening for CRC. A Cochrane
systematic review examined the effect of personalised
risk communication for informed decision-making in
uptake of medical screening compared to general infor-
mation [5]. Overall, providing a numerical risk score or
a categorised risk (e.g. ‘low’, ‘medium’, ‘high’) increased
informed choice (odds ratio 3.65, 95% CI 2.13 to 6.23,
for random effects) and screening uptake (odds ratio
1.15 95% CI 1.02 to 1.29). However, the included studies
covered a wide range of screening tests and thus the re-
sults were heterogeneous. Of the studies involving CRC,
only one [6] used a calculated numerical risk score, lead-
ing to greater knowledge but non-significant lower
intention and uptake; it did not report changes in in-
formed choice. Three studies used a categorised risk
score; these did not assess knowledge or informed
choice, but indicated a small, significant increase in up-
take of screening [7–9]. The authors concluded that the
evidence that personalised risk communication increases
screening uptake is weak. Further, although some in-
cluded colonoscopy, all of the reviewed studies involving
CRC screening related to first-line screening only. Sub-
sequent to the commencement of our study, results have
been published from the CRISP-Q [10] study where pa-
tients in GP waiting rooms in Australia were given five
different hypothetical average and increased risk presen-
tations and asked to decide for each, based on the risk
presented, whether they would choose either no screen-
ing, a faecal occult blood test, or a first-line screening
colonoscopy. Trends existed for selection of more ap-
propriate screening options both for the risk presenta-
tion showing an absolute risk of CRC along with a
government recommendation and the one showing an
‘expected frequency tree’. Very recently published results
from a Danish RCT found that a web-based decision aid
aimed at screening-naïve individuals with lower educa-
tional attainment did not affect informed choice or
knowledge of CRC screening but there were trends to-
wards improved uptake and positive attitudes towards
CRC screening compared with the control group [11].
Currently, participants in the SBoSP are offered colon-
oscopy when they have f-Hb ≥ 80 μg Hb/g faeces. This
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threshold for positivity is much higher than that used in
other countries. Any measurable f-Hb confers some risk
of neoplasia, and sensitivity for cancer detection in-
creases as the f-Hb threshold is lowered [12]. It is likely
that those screening participants receiving a letter
informing them that they have had a negative screening
test result are largely unaware that around half of all
CRC in the screened population arise in those with f-Hb
below the threshold of 80 μg Hb/g faeces. Thus, we
aimed to investigate the impact of providing the
screened population with novel, hypothetical persona-
lised risk information designed to enable a completely
transparent informed choice as to whether or not to
undergo colonoscopy following screening with FIT. In
addition to the effect on level of informed choice, we
also investigated the potential impact that providing
screening participants with such information would have
on colonoscopy services as well as emotional responses
such as increased anxiety about the screening process.
Methods
Setting
The National Health Service (NHS) in Scotland provides
comprehensive health care to all permanent residents,
funded by general taxation but free at the point of use,
based on need. Currently in Scotland, all men and women
aged 50–74 years and registered with a NHS general prac-
titioner (GP) practice are invited to participate in bowel
screening every 2 years. About 850,000 invitations are sent
each year via the Bowel Screening Scotland information
technology system (BoSS), which holds a database of all
eligible participants. The most recently published Key Per-
formance Indicators report uptake of FIT in the SBoSP at
63.9%, with a positivity rate of 3.1%. Colonoscopy uptake
in those with a positive screening test (f-Hb ≥ 80 μg Hb/g
faeces) was reported as 77.3%.
Design
The full study protocol has been published previously
[13]. Novel personalised risk information materials (both
for risk of having CRC and the risks associated with col-
onoscopy) were developed for a simple three arm rando-
mised controlled trial (RCT) design. The three study
arms were as follows: (1) numerical personalised risk in-
formation, (2) categorical risk information and (3) posi-
tive screening test result. Arm 3 was effectively a control
group reflecting current practice to allow comparison of
likely uptake of colonoscopy with the groups receiving
personalised risk information.
The materials were co-developed at workshops each
attended by 8 to 12 Patient and Public Involvement
(PPI) representatives, the core project team and an info-
graphics expert. The representatives were members of
the Health and Behaviour PPI group based at The
University of Stirling and were selected to be representa-
tive of the screening population. Draft materials were
presented at the workshop and completed by the PPI
representatives before being reviewed in detail from a
lay perspective, with PPI feedback also gathered on the
perceived burden associated with receiving and complet-
ing the materials. These workshops were audio recorded
and the materials were revised according to the feedback
provided. Workshops continued to be held until agree-
ment was reached on finalised materials.
A Scenario Letter/s Booklet was developed for each
study arm, with risk information for those in the numer-
ical and categorical risk groups provided in a visual for-
mat (based on infographics), aimed to be understandable
across education levels, as guided by recommendations
[14, 15]. For study arms 1 and 2, three hypothetical
screening result letters were included in the booklet,
each giving a different level of risk of having bowel can-
cer. In the numerical risk group (Additional file 1), the
highest risk letter informed the participant that, based
on FIT screening result, age and gender, 1 in 40 people
like them would have bowel cancer diagnosed in the
next 2 years. This ratio was derived from the number of
people with a positive screening test result (f-Hb ≥ 80 μg
Hb/g faeces) in the SBoSP pilot demonstration of FIT
[1] who had CRC diagnosed in the 2 years following
their test result (screen-detected CRC plus interval
CRC). The level of risk in the moderate risk letter was 1
in 1600, representing the number of people in the FIT
pilot with f-Hb 1 to 79 μg Hb/g faeces who were diag-
nosed with an interval CRC. The lowest risk provided
was 1 in 3500, representing the number of people in the
FIT pilot with f-Hb reported as 0 μg Hb/g faeces who
had an interval CRC. A green ‘donut’ style infographic
with a red segment representing the ratio presented was
used for each level of risk. The three letters provided to
those randomised to the categorical risk arm (Add-
itional file 2) included a ‘traffic light’ style infographic to
convey that the participant was either in the lowest risk
group (highlighted in green), moderate risk group (amber)
or highest risk (red). A short paragraph explaining what
was meant by each risk group was provided below the
infographic. Those randomised to the control group
received a scenario letter which was representative of the
current letter sent to SBoSP participants following a
positive bowel screening test based on the cut-off f-Hb of
≥ 80 μg Hb/g faeces (Additional file 3). The negative
screening result letter was not provided to the control
group since the intention was to mimic current practice,
which would not involve this group being offered
colonoscopy.
In addition to Scenario letters, the pack which the
three groups received in the mail also included two in-
formation/education booklets about bowel screening and
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colonoscopy: the current Bowel Screening Test Booklet
(Additional file 4; explaining the benefits of participating
in screening as well as explaining that not all CRC are
detected by screening) and a Colonoscopy Information
Booklet (Additional file 5; based on the materials cur-
rently provided to those who are offered colonoscopy
following a positive screening test, explaining the pro-
cedure including preparation and associated risks). A
Study Questionnaire (Additional file 6) was also devel-
oped at the PPI workshops and sent to all participants.
The primary outcomes were to assess the impact of
different presentations of risk information on informed
choice and intention to take up an offer of colonoscopy
after FIT. The informed choice measure was adapted
from Smith et al. [16] who applied a multidimensional
model of informed choice (originally developed and vali-
dated for antenatal screening for Down’s syndrome [17,
18]) and combined the constructs of (a) knowledge, (b)
attitudes and (c) behaviour to assess the extent to which
people made an informed choice about participating in
screening using gFOBT.
Measures
Table 1 summarises the various measures to determine
level of informed choice, including intention to accept
an offer of colonoscopy, decisional conflict, planned be-
haviour, knowledge (based on the information provided
in the Bowel Screening Test booklet and the Colonos-
copy Information Booklet) and attitudes towards bowel
screening and colonoscopy. A secondary outcome was
to assess participants’ responses to receiving personal
risk information. In addition to knowledge and attitudes
to screening and risk, this also included emotional re-
sponses including anxiety and level of distress felt when
reading the materials supplied. Details of these measures
are also listed in Table 1.
Pretesting of materials
One hundred forty-four adults registered on the SBoSP
database (age range 50 to 74 years), regardless of whether
or not they had previously participated in screening, were
selected for invitation for pilot testing prior to the mate-
rials being refined and finalised for main recruitment. All
age quintiles, Scottish Index of Multiple Deprivation
(SIMD) categories and both genders were represented in
the sample with the target recruitment weighted towards
those groups who may be less likely to participate, based
on response levels obtained from our large-scale question-
naire study on bowel screening [22], with the aim of
achieving a balanced sample of participants. Invitations
were not sent to those who had recently participated in
screening or were shortly to be invited for screening
(within 6 months of either event) to limit any confusion
between the study materials and an actual screening
result. Invitation letters were sent on behalf of the Princi-
pal Investigator, Director of the SBoSP, to ask if they
would like to participate in a survey to assess their re-
sponse to an offer of colonoscopy in relation to an esti-
mated personalised risk of having cancer. A full patient
information sheet and a response form were included
along with a pre-paid envelope for return. In line with
published criteria for increasing recruitment [23], invita-
tion letters were personally addressed, included stamps ra-
ther than franked return envelopes and used coloured ink.
The response form also included an option to consent to
taking part in a short follow-up interview by telephone.
On receipt of the returned completed response form, par-
ticipants were randomised to receive the study materials
from one of the three study arms. Blinded randomisation
with minimisation on variables related to risk (i.e. age,
SIMD, gender) was carried out via MINIM software by an
individual independent to the process of running the
study. Data on screening history (i.e. previous participa-
tion/failure to participate/been offered a colonoscopy) was
also collected at the time of sampling, as these strongly
predict screening uptake [24]. Return of the completed
questionnaire was considered as an implied consent. Of
the 144 participants invited for pilot testing, 39 replied
with 21 agreeing to take part; 15 completed and returned
the study materials. Fourteen out of the 15 participants re-
corded an adequate knowledge score indicating that the
information materials were effective in conveying the rele-
vant facts relating to bowel screening and colonoscopy.
The response to the materials was very positive with all
participants agreeing that the materials were easy-to-
understand. The results of the pilot testing did not indi-
cate a need for any modifications to the methodology for
the main recruitment phase of the RCT.
Main recruitment
Following the pilot testing and finalisation of study ma-
terials, a total of 2767 participants were invited to par-
ticipate in the main study between February and July
2019, following the same process as described for the
pilot testing. The required sample size was 300 (100 in
each group), calculated to have 83.7% power of detecting
a 1 point increase in knowledge (intervention versus
control), and a 2-point difference in attitudes (based on
existing study means/SDs [16, 17]), using a one-way ana-
lysis of variance (ANOVA).
Procedures
Knowledge, attitudes and intention to take up colonos-
copy were compared between the study arms to assess
whether providing personalised information on CRC risk
led to informed choice. Participants were deemed to be
fully informed if they demonstrated adequate knowledge
and attitudes which match their intention, i.e. a positive
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attitude to colonoscopy along with the intention to
undergo colonoscopy, or a negative attitude to colonos-
copy along with the intention not to undergo colonos-
copy. A partially informed choice was one where either
the participant had adequate knowledge but their atti-
tudes did not match their intention or inadequate know-
ledge but attitudes matched intention. An uninformed
choice was when the participant neither had adequate
Table 1 Summary of study measures
Measure Booklet Repeated
measure?










Single question to measure intention to accept an
offer of colonoscopy as a proxy measure for










The informed subscore (items 1–3) from the
Decisional Conflict Scale [19] was used to assess the
extent to which participants felt informed about
their decisions. These items are: “I know which
options are available to me”, “I know the benefits of
each option” and “I know the risks and side effects
of each option”, scored on a 7-point scale from
“strongly agree” to “strongly disagree”.
In accordance with scoring system supplied
with the tool: responses to each of the three
items scored on a scale from 0 to 6 and total
score calculated by multiplying the average of
the three scores by 16.6 to give a score
between 0 and 100. A lower score indicates a
more informed choice. Scores lower than 25 are
associated with following through with
decisions whereas scores greater than 37.5 are
associated with decision delay or feeling unsure









Two additional 7-point Likert scale responses (from
“strongly agree” to “strongly disagree”) to two state-
ments: “If I received information that (1) my risk of
bowel cancer was 1 in 40, (2) my risk of bowel can-
cer was high or (3) the result of the test I provided
showed that further investigation is required, then I
would intend to have a colonoscopy” and “If I was
told that (1) I had a 1 in 40 chance of having bowel
cancer, (2) I was in the group at highest risk of
bowel cancer or (3) my screening test was abnormal
meaning that there was a risk I had bowel cancer,
then I would definitely choose to have a
colonoscopy”.
Scores ranged from 1 to 7 for each statement,
with a higher score representing greater
agreeability with the statement.
Knowledge Questionnaire
Booklet
No Eight questions (four concept, four numerical); 1
point per correct response with the exception the
numerical question relating to the number of
people surviving bowel cancer if detected early,
worth 2 points.
Maximum knowledge score of 9. As with Smith
et al. [16] a pass mark of 50% or greater (≥ 5)




No Nine-item scale scored on a 5-point Likert scale from
“strongly agree” to “strongly disagree”. Items in-
cluded discomfort and embarrassment during col-
onoscopy, side-effects of bowel preparation and
beliefs around reducing the risk of dying from
bowel cancer.
The range for the total score was 9 to 45. A
higher score reflected a more positive attitude
towards having a colonoscopy. In keeping with
Smith et al. [16], the median value of the
sample was used to classify participants’






No The questionnaire measured anxiety using a
previously-validated six-item version of the State
Trait Anxiety Inventory (STAI) [20]. An example item
is the statement “I am worried”, with a choice of
four responses on a scale from “not at all” to “very
much”.
The scoring system was developed to allow
comparison with the normative values given for
the original 40-item scale [21]. Total possible
scores ranged from 20 to 80 with a higher score







No Two Likert-type questions: “I found the information
presented easy to understand” and “I found the in-
formation presented distressing” scored on a 7-
point scale from “strongly agree” to “strongly
disagree”.
Scores ranged from 1 to 7 for each statement,
with a higher score representing greater





No Single question for participants if they had







No Open-ended question encouraging additional free
text comments.
Thematic qualitative analysis.
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knowledge or attitudes matching their intention.
Between-group differences in outcomes on the scales re-
lating to knowledge, attitudes and behaviour were ana-
lysed as continuous variables via ANOVA or Student’s t
test. The number of participants reporting an intention
to accept the offer of colonoscopy from each scenario
was used to estimate total uptake, and hence the poten-
tial impact on colonoscopy services for numerical versus
categorical presentation of personalised risk information,
in comparison to the current positive/negative cut-off.
Thirty participants were sampled for semi-structured
telephone interview, 10 per arm, from those consenting to
be telephoned. All who answered the telephone call agreed
to participate and those who could not be reached were re-
placed in the sample by another consenting participant.
Verbal consent was confirmed at the start of the telephone
interview, including consent for audio-recordings. The tele-
phone interviews included open-ended questions relating
to emotional responses to the materials and understanding
of what was meant by the risk categories, as well as asking
how participants perceived the risk of undergoing a colon-
oscopy versus that of having CRC in each of the given sce-
narios. The recruitment of n = 30 to the qualitative
interviews was based on the number required for saturation
of themes in previous research by the authors; this was also
achieved for this sample. Each interview was analysed on a
line-by-line basis for key themes/patterns and thematic
qualitative analysis was used to compare responses between
those who intended and did not intend to take up the offer
of colonoscopy. Differences with respect to age, sex, SIMD,
and previous CRC screening participation and/or previous
colonoscopy were also explored.
Results
Two thousand seven hundred sixty-seven people were in-
vited to participate in the main study phase, with 434
(15.7%) people indicting they would be willing to partici-
pate. Of the 434 people agreeing to participate, 145, 144
and 145 were randomised into the numerical risk arm, cat-
egorical risk arm and the positive result letter arm, respect-
ively. Three hundred nine (71.0%) participants completed
and returned the materials, 100 from the numerical risk
group (69.0%), 104 from the categorical risk group (72.2%)
and 104 from the control group (71.7%). Of those who
completed and returned the study materials, 91.0%, 93.3%
and 90.4% in the respective study arms had previously par-
ticipated in the SBoSP. Demographic details of those invited
and responding to the study invite are shown in Table 2.
Participants’ responses to whether or not they would
choose to have a colonoscopy in each of the risk scenar-
ios are shown in Table 3. In the two study arms receiv-
ing risk information, the proportion of participants who
said they would intend to undergo colonoscopy
decreased as risk level was lowered. This fall in intention
was statistically significant in the numerical risk study
arm between both of the reductions in risk (1 in 40 cf. 1
in 1600: p = 0.0002 and 1 in 1600 cf. 1 in 3500 p = 0.003)
and in the categorical risk study arm between the mod-
erate and lowest risk scenarios (p < 0.0001). Although
the number of participants in the categorical study arm
who said they would undergo colonoscopy if they were
told they were in the moderate risk group was 10%
greater than in the equivalent group in the numerical
arm (88.8% vs. 78.7%), this difference was not statisti-
cally significant (p = 0.067). Mean informed subscore of
the Decisional Conflict Scale and numbers of partici-
pants with scores associated with implementing deci-
sions (scores < 25) for each study arm are also shown in
Table 3. No significant differences in mean informed
subscore were observed between the study arms.
For the two additional 7-point Likert scale statements
regarding intention to undergo colonoscopy (e.g. “If I re-
ceived information that my risk of bowel cancer was 1 in
40 then I would intend to have a colonoscopy” and “If I
was told that I had a 1 in 40 chance of having bowel
cancer then I would definitely choose to have a colonos-
copy”), all three groups showed a high level of agree-
ment with the statements for the highest risk scenarios
(all mean scores ≥ 6.5 out of 7) and even in the lowest
risk groups in the numerical and categorical arms, par-
ticipants still responded positively. Mean scores in each
study arm for these items are shown in Table 4.
Mean knowledge and attitude scores for each study
arm are shown in Table 5. All participants who com-
pleted the knowledge questions (97, 102 and 104 in the
numerical risk, categorical risk and positive result letter
arms, respectively) recorded a score of ≥ 5, indicating ad-
equate knowledge, with the exception of one in the cat-
egorical risk group and two in the positive result letter
group. No significant differences in total knowledge or
attitude scores were observed between the three study
arms (p > 0.05). This would be expected as all groups re-
ceived the same information materials, with only presen-
tation of risk differing. Table 6 shows the number of
participants in each study arm who correctly answered
each item in the knowledge section of the questionnaire.
For the highest risk groups only (risk of 1 in 40 in the
numerical group, highest risk in the categorical group and
the positive result letter group), Table 7 shows the num-
ber of participants in each study arm who were deemed to
have made a fully informed, partially informed or unin-
formed choice about whether or not to have a colonos-
copy. One person in the numerical study arm and one
person in the positive result letter study arm made a fully
informed choice not to have a colonoscopy, while the re-
mainder of those who were classed as fully informed said
they would take up the offer of colonoscopy. No
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significant difference was found when comparing the level
of informed choice between the three study arms (p >
0.05).
The mean anxiety score for those in the positive result
letter arm (36.8, 95% CI 33.9 to 39.8) was statistically sig-
nificantly higher than for those in the numerical study
arm (32.2, 95% CI 29.8 to 34.6, p = 0.02) and those in the
categorical study arm (33.8, 95% CI 30.1 to 35.4, p = 0.04).
The proportion of subjects who reported that they
strongly agreed with the statement that the information
was easy to understand was 61.2%, 72.5% and 66.3% in
numerical risk group, the categorical risk group and
positive result letter group, respectively. The differences
between the study arms were not statistically significant
(p > 0.05). No participants across any of the study arms
showed any disagreement with this statement. 19.1% of
those in the numerical risk group, 24.0% of those in the
categorical risk group and 29.6% of those in the positive
result letter group agreed to some extent that they found
the information presented distressing (p > 0.05), al-
though less than 5% in each arm strongly agreed.
One hundred twenty-four (40.3%) of all participants re-
ported that they had previously had a colonoscopy, with
43 (43.0%) in the numerical risk study arm, 41 (39.4%) in
the categorical risk arm and 40 (38.5%) in the positive re-
sult letter arm. Logistic regression analysis showed that
previous experience of colonoscopy did not appear to have
an impact on intention in the highest and moderate risk
groups for the two risk information groups or for the posi-
tive result letter study arm (p > 0.05). In the lowest risk
group in the categorical risk study arm, however, people
were more likely to report that they would accept the offer
of a colonoscopy if they had previously had the test (odds
ratio [OR] 3.13, 95% CI 1.20 to 4.02). Overall, previous
colonoscopy experience was associated with a positive
score for attitude towards bowel screening and colonos-
copy (OR 1.81, 95% CI 1.11 to 2.95), but not when
assessed for the individual study arms (p > 0.05). Previous
experience of colonoscopy did not show association with
STAI anxiety scores. Even when classifying participants
according to a STAI score cut-off of > 40 (considered to
indicate clinically significant symptoms of anxiety [25]),
the ORs to indicate a relationship with previous colonos-
copy experience were not statistically significant for any of
the three study arms, nor overall (p > 0.05).
Thirty participants took part in telephone interviews,
with 10 from each of the three study arms. All partici-
pants across all groups said that they found the scenario
letters easy-to-understand acceptable and would not put
them off from future participation in the screening
programme. In general, participants had a good under-
standing of how increasing age and the amount of blood
found in the screening test sample act as risk factors for
CRC, although many were not clear on male sex as a
risk factor. Participants in the numerical and categorical
risk information groups were asked about their under-
standing of the different risk groups they were presented
with, their reasons for deciding whether or not they
would accept the offer of colonoscopy and how they felt
the risks of the procedure compared to the benefits. Of














Male 1391 (50.3) 224 (51.6) 154 (50.0) 50 (49.5) 50 (48.1) 54 (52.4)
Female 1376 (49.7) 210 (48.4) 154 (50.0) 51 (50.5) 54 (51.9) 49 (47.6)
Age (years)
50–54 354 (24.8) 88 (20.3) 57 (18.5) 16 (15.8) 20 (19.2) 21 (20.4)
55–59 332 (20.8) 84 (19.4) 52 (16.9) 19 (18.8) 17 (16.3) 16 (15.5)
60–64 576 (19.3) 105 (24.2) 76 (24.7) 26 (20.8) 25 (24.0) 25 (24.3)
65–69 460 (16.6) 73 (16.8) 59 (19.2) 21 (20.8) 18 (17.3) 20 (19.4)




779 (28.2) 80 (18.4) 51 (16.6) 16 (15.8) 16 (15.4) 19 (18.4)
2 623 (22.5) 85 (19.6) 59 (19.2) 20 (19.8) 21 (20.2) 18 (17.5)
3 514 (18.6) 83 (19.1) 55 (17.9) 20 (19.8) 17 (16.3) 18 (17.5)
4 439 (15.9) 95 (21.9) 72 (23.4) 21 (20.8) 26 (25.0) 25 (24.3)
5 (least
deprived)
412 (14.9) 91 (21.0) 71 (23.1) 24 (23.8) 24 (23.1) 23 (22.3)
*Scottish Index of Multiple Deprivation
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Table 3 Comparison of intention to undergo colonoscopy between risk categories and study arms
Numerical risk arm Categorical risk arm Positive result letter arm p value
1 in 40/highest risk/positive result letter
Yes 90 (96.8%) 87 (95.3%) 81 (93.1%) 0.493
No 1 (1.1%) 0 (0.0%) 1 (1.1%)
Unsure 2 (2.2%) 6 (6.5%) 5 (5.7%)
1 in 1600/moderate risk
Yes 74 (78.7%) 79 (88.8%) – 0.067
No 5 (5.3%) 1 (1.1%) –
Unsure 15 (16.0%) 9 (10.1%) –
1 in 3500/lowest risk
Yes 50 (58.1%) 54 (60.7%) – 0.734
No 12 (14.0%) 15 (16.9%) –
Unsure 24 (27.9%) 20 (22.5%) –
Decisional Conflict Scale informed subscale score
1 in 40/highest risk/positive result letter
0 56 (60.2%) 66 (71.0%) 60 (68.2%)
1–25 34 (36.6%) 26 (28.0) 25 (28.4%)
> 25 3 (3.2%) 1 (1.1%) 3 (3.4%)
Mean score (95% CI) 6.4 (4.0–8.9) 4.3 (2.8–5.8) 5.7 (3.5–7.8) 0.353
1 in 1600/moderate risk
0 52 (56.5%) 61 (65.6%) –
1–25 36 (39.1%) 30 (32.3%) –
> 25 4 (4.3%) 2 (2.2%) –
Mean score (95% CI) 7.2 (4.9–9.6) 6.4 (3.8–9.0) – 0.624
1 in 3500/lowest risk
0 50 (55.6%) 54 (58.7%) –
1–25 35 (38.9%) 34 (37.0%) –
> 25 5 (5.6%) 4 (4.3%) –
Mean score (95% CI) 7.8 (5.4–10.1) 8.4 (5.3–11.6) – 0.732
Table 4 Mean scores for additional statements regarding intention to undergo colonoscopy (maximum = 7)
Numerical risk arm (mean
score out of 7, (95% CI))
Categorical risk arm (mean
score out of 7, (95% CI))
Positive result letter arm (mean
score out of 7, (95% CI))
p value
“If I received information that my risk of bowel cancer was 1 in x then I would intend to have a colonoscopy”
1 in 40/highest risk/positive result letter 6.4 (6.1–6.6) 6.7 (6.5–6.8) 6.5 (6.3–6.7) 0.085
1 in 1600/moderate risk 5.4 (5.1–5.8) 6.4 (6.2–6.6) – < 0.0001
1 in 3500/lowest risk 5.0 (4.7–5.4) 5.3 (4.9–5.6) – 0.3484
“If I was told that I had a 1 in x chance of having bowel cancer, I would definitely intend to have a colonoscopy”
1 in 40/highest risk/positive result letter 6.5 (6.3–6.7) 6.7 (6.6–6.9) 6.7 (6.6–6.9) 0.124
1 in 1600/moderate risk 5.6 (5.2–5.9) 6.4 (6.2–6.6) – < 0.0001
1 in 3500/lowest risk 5.0 (4.7–5.4) 5.1 (4.7–5.6) – 0.6568
Scoring system: “strongly disagree” = 1, “disagree” = 2, “slightly disagree” = 3, “neither agree or disagree” = 4, “slightly agree” = 5, “agree” = 6, “strongly agree” = 7
Digby et al. BMC Medicine          (2020) 18:285 Page 8 of 13
those who completed a telephone interview, four partici-
pants in the numerical risk information group and six
participants in the categorical risk information group
had indicated on their returned materials that they
would accept the offer of colonoscopy in all three risk
scenarios. Explanations included “Although the medium
and low scenarios had a much reduced chance of devel-
oping bowel cancer, if I was offered a colonoscopy I
would accept, as I wouldn’t think it was being offered
unless there was justifiable reason for doing the proced-
ure” (numerical risk group) and “For peace of mind,
even although you were low risk you would say ‘let’s
know for certain’” and “I feel that if there was even the
slightest risk of developing bowel cancer, the discomfort
of a colonoscopy is a small price to pay for early detec-
tion” (categorical risk group). Two participants in the
numerical risk group reported that they would like to be
told either way whether or not they should have a colon-
oscopy, with one saying “I would like to know ‘yes’ you
have bowel cancer or ‘no’ you do not have bowel cancer.
I feel that telling me I have a 1 in 400 or 1 in 4000
chance of getting bowel cancer is as much use to me as
being told my chances of dying as a result of a car crash
or being hit by a bus; just something else to worry
about!”. Conversely, two participants in the categorical
risk group reported that they would like to be provided
with a numerical level of risk, saying “I feel if percent-
ages of risk and recovery were given, I could have made
a more informed decision” and “I would have appreci-
ated more hard facts at this stage, actual percentages of
those in each of the risk groups subsequently found to
have bowel cancer”. The majority of participants across
all three study arms expressed that they felt that the
risks associated with colonoscopy were outweighed by
the benefits of having a colonoscopy. No differences in
themes identified in the qualitative data were found be-
tween different age quintiles, sexes or SIMD quintiles.
The questionnaire also allowed participants to record
their views on the information presented using free text.
In addition to the participants who completed telephone
interviews, a further 172 patients (59, 64 and 49 in the
numerical risk arm, categorical risk arm and positive
Table 5 Knowledge and attitude scores and intention to undergo colonoscopy in each study arm
Numerical risk arm Categorical risk arm Positive result letter arm
Knowledge score (mean)
Concept, max. score 4 (95% CI) 3.7 (3.6–3.8) 3.7 (3.5–3.8) 3.6 (3.4–3.7)
Numerical, max. score 5 (95% CI) 4.7 (4.6–4.8) 4.6 (4.5–4.8) 4.5 (4.4–4.7)
Total, max. score 9 (95% CI) 8.4 (8.2–8.6) 8.3 (8.1–8.5) 8.1 (7.9–8.4)
No. with adequate knowledge (score ≥ 5) 96/97 (99.0%) 100/102 (98.0%) 102/104 (98.1%)
Attitude
Mean score (95% CI) 38.3 (37.3–39.4) 38.8 (37.9–39.7) 38.7 (37.6–39.8)
No. with positive attitude towards colonoscopy (score ≥ 39) 48/93 (51.6%) 59/97 (60.8%) 63/101 (61.4%)




















Q3: Do you think that all cancers bleed, meaning that the bowel cancer screening test will








Q4: The bowel preparations required before a colonoscopy will mean you experience urgency











Q6: How many people who have a colonoscopy will experience bowel perforation (tear of the











Q8: The sedation used during colonoscopy occasionally cause problems with breathing, heart
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result letter arm, respectively) took this opportunity.
Twenty-eight (47.5%), 18 (28.1%) and 30 (61.2%) partici-
pants, respectively in each study arm, made comments
giving positive feedback regarding the ease of under-
standing and acceptability of the materials provided. Par-
ticipants in the risk information arms also spoke
positively about making an informed choice. One par-
ticipant in the numerical risk arm said “Though I would
be concerned about any future risk of cancer, I prefer an
honest approach to the situation”. Similarly, those in the
categorical risk arm wrote comments such as “Gave me
a clear understanding i.e. risk. Would prefer to know as
much as possible of my situation and risk level”. How-
ever, one participant in the categorical risk arm said, re-
garding a previous screening experience, “I didn’t receive
a booklet regarding risks - glad I didn’t, I now feel more
anxious and concerned if I need a third colonoscopy!
Sometimes ignorance is bliss!” and another in the posi-
tive result letter arm said “Some people will think it’s
embarrassing or worry too much given too many de-
tails”. A few participants commented on the use of col-
ours in the infographics, with one participant saying it
was helpful (categorical risk group) while one in each of
the risk information groups said the use of red was
“frightening”. Some participants in the categorical risk
arm gave feedback that they were not clear on the levels
of risk provided to them, for example “I think I under-
stand what is meant by ‘lowest risk’ and ‘highest risk’,
but ‘moderate risk’ is more difficult. Can you provide
more information about this category? I think I would
err on the side of caution and have a colonoscopy - if
only to reduce ‘moderate risk’ to ‘lowest risk’” and “The
letters would suggest everyone, regardless of risk will be
offered a colonoscopy. However, if there is a “not cur-
rently at risk” group then this should be incorporated”.
Three participants also commented that their responses
to the materials may have been different if they received
them in real life, rather than hypothetically.
Discussion
When given the choice whether or not to have a colonos-
copy, the majority of participants reported that they would
take up the offer, regardless of the level of risk that they are
provided with. Responses to the open-ended questions in
the questionnaire and during telephone interviews demon-
strated a theme that many people consider the risk of CRC
as being more serious than the risks of colonoscopy, even
when the latter is statistically more likely. Existing data on
FIT in the SBoSP indicates that 2.5%, 38.8% and 58.7% of
people would be in the highest, moderate and lowest risk
groups, respectively. Combining these proportions with the
findings of this study suggests that if all bowel screening
participants were offered an informed choice to have colon-
oscopy, over two thirds of participants would opt to have
the test. This would represent an increase in the current
number of screening colonoscopies performed in Scotland
from approx. 14,000 per annum to approx. 400,000 per
annum. Clearly, an additional demand of this magnitude on
colonoscopy services would not be manageable, with only a
very small proportion of cancers and pre-cancers detected.
There are currently no accepted measures of informed
choice in CRC screening. Our study has shown that
bowel screening participants generally respond very
positively to receiving personalised risk information
using infographics. An encouraging finding was that pro-
viding more information does not appear to make
people more anxious, with mean anxiety scores lower in
those in the groups receiving risk information compared
with the control arm. The proportion of participants
who reported decisional conflict was very low in both
groups who received risk information, for all three levels
of risk. However, responses to the intention question
used as a proxy for behaviour showed a greater level of
uncertainty was apparent with the lowest risk groups (1
in 3500 or lowest risk); over a fifth of participants re-
ported that they were unsure whether or not they would
decide to have a colonoscopy. The finding that those at
lowest risk were not adequately reassured that colonos-
copy was not required indicates that providing partici-
pants with a fully informed choice in this setting may be
inappropriate if it is not accompanied by some form of
advice. Similarly, the qualitative results revealed that
there was some uncertainty around the meaning of the
categorical risk groups, with ‘moderate risk’ in particular
perhaps lacking clarity. This feedback also suggests that
providing risk information alongside more explicit ad-
vice on whether or not colonoscopy is required is likely
to be a more pertinent approach. This may also have the
Table 7 Comparison of level of informed choice between study arms
Numerical risk arm (1 in 40) Categorical risk arm(highest risk) Positive result letter arm
Fully informed choice* 46/85 (56.5%) 54/81 (65.4%) 51/80 (63.8%)
Partly informed choice** 38/85 (44.7%) 28/81 (34.6%) 28/80 (35.0%)
Completely uninformed choice*** 0/85 (0.0%) 0/81 (0.0%) 1/80 (1.3%)
*Adequate knowledge + positive attitude + decision to undergo colonoscopy OR adequate knowledge + negative attitude + decision not to
undergo colonoscopy
**Adequate knowledge + negative attitude + decision to undergo colonoscopy OR inadequate knowledge + positive attitude + decision to undergo colonoscopy
***Inadequate knowledge + negative attitude + decision to undergo colonoscopy OR *** inadequate knowledge + positive attitude + decision not to
undergo colonoscopy
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desirable effect of increasing colonoscopy uptake in
those at highest risk above its current rate of 77%. The
majority of participants in the two risk information
groups were classified as being fully informed, although
this was similarly true of the positive result letter study
arm; being representative of current practice, this is
reassuring.
A major strength of the study is that development of
the study materials was achieved using iterative feedback
provided by a PPI group who were selected to be repre-
sentative of the population eligible for bowel screening
in Scotland. They unanimously agreed on the layout,
content and readability of the final materials giving the
study team confidence that the materials would provide
an informed choice about whether or not to undergo a
colonoscopy. Indeed, the vast majority of participants in
all study arms and across all risk categories recorded
scores on the informed subscore of the Decisional Con-
flict Scale which are associated with implementing deci-
sions. In addition, final recruitment of participants was
positive, with targets of 100 in each study arm being
met. A further strength is that study invitations were
weighted towards those in demographic groups previ-
ously shown to be least likely to participate. Although
participation was still lowest in those in the most de-
prived quintiles, this would have been more pronounced
without the selective invitation process. Comparable
scores were recorded across the three study arms for
knowledge of CRC screening and colonoscopy. This
would be expected since all three received the same in-
formation materials, but it is reassuring that a similar,
high level of understanding was demonstrated by the
three groups.
The main limitation of the study is we cannot account
for the likely gap between intention and behaviour. In-
deed, free text comments in the study questionnaire in-
cluded indications that the thought process when deciding
whether or not to undergo colonoscopy may be different
in a “real life” scenario. To fully assess the impact of offer-
ing a more informed choice on uptake of screening colon-
oscopy would require incorporation of a full scale RCT
into the screening programme invitation process. How-
ever, the results of this study suggest that even with ad-
justment for the intention-behaviour gap, a huge increase
in demand on the colonoscopy resource would still occur.
Since the study invitation was separate to the actual
screening invitation, with the cohort including people
who had not previously taken part in screening, the re-
sults are applicable to the overall population eligible for
screening. However, a further potential limitation of the
study is participant bias, in that those who accepted the
study invitation and then completed and returned the
materials are those who are more likely to be more
health conscious and participate in screening. However,
in actual practice, the offer of informed choice following
FIT would only be made to those who had completed
the test, so we believe this would be an acceptable, if not
desirable, bias. The finding that 40% of participants had
previously had a colonoscopy may also represent partici-
pation bias. It is likely that a reasonable proportion of
the screening population as a whole, given the age range,
will have had previous experience of colonoscopy but we
do not have data available for comparison to measure
the significance of this as a study limitation.
Numerical risks were calculated according to three
subgroups of f-Hb only. In reality, the level of risk given
would be further refined according to age and gender.
The use of only three numerical risk levels (1 in 40, 1 in
1600 and 1 in 3500) allowed intra-participant compari-
son between all responses to the three scenarios in this
study arm. For the same reason, all participants in the
numerical and categorical risk arms received all three
levels of risk within their scenario booklet (1 in 40, 1 in
1600 and 1 in 3500 or highest, moderate and lowest risk,
respectively). However, this opportunity to consider each
risk scenario by contrasting with the other two may have
had an effect on their reported intention. Therefore,
intention may differ if providing personalised risk in
reality, where participants only receive one level of risk.
It should also be noted that was only possible to
present risk scenarios using existing SBoSP data from
the numbers of screen-detected and interval cancers.
Since the screening programme aims to detect both
CRC and its pre-cursors, the calculated risk scenarios
would be an underestimate of the risk of all screen-
relevant lesions.
Some participants reported that they would like to con-
sult a medical professional about their decision whether
or not to accept the invitation for a colonoscopy. Indeed, a
new BMJ guideline for CRC screening [26] is the first to
avoid a blanket recommendation for CRC screening in
those above a certain age and instead suggests a persona-
lised and risk-based approach should be made between
the individual and the clinician. The guideline recom-
mends that using a shared decision tool such as the
QCancer® calculator (qcancer.org/15yr/colorectal/) which
incorporates age, sex, ethnicity, BMI, smoking status and
family history of gastrointestinal cancer to estimate a per-
sonal CRC risk over the next 15 years.
Another theme identified in the qualitative analysis
was that people thought that colonoscopy would not be
offered to them unless it was required. The trust that
the UK population holds in the NHS may be a factor
contributing to the majority of people reporting that
they would intend to have a colonoscopy if it was of-
fered, regardless of risk. If the same protocol was
followed in other countries, different results may occur
with different healthcare systems to that of the UK.
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Furthermore, it is important to note that the f-Hb
threshold of 80 μg Hb/g faeces used for positivity in the
SBoSP is much higher than that used in other countries.
Therefore, if a similar approach to ours was adopted in
other countries, the moderate risk scenario would cover
a much narrower f-Hb range than that of 1 to 79 μg Hb/
g faeces in this study. Given our results, it is possible
that the blanket offer of colonoscopy to all screening
participants may contradict the key principles of screen-
ing laid out in the seminal work by Wilson and Jungner
[27] and the UK National Screening Committee [28].
These principles outline that in screening programmes
the costs and risks (physical and psychological) should
be balanced against the benefits and that a suitable cut-
off should be defined and agreed. Alternative approaches
to improve transparency of information offered to
screening participants could also be explored, such as
providing those with a negative result with their numer-
ical f-Hb, so that they themselves are aware of the prox-
imity of their screening result to the threshold. This idea
is supported by the findings of a recent study from Italy
demonstrating that those with two consecutive negative
screening test results, but a cumulative f-Hb above the
cut-off for positivity had a significantly increased risk of a
future diagnosis of advanced neoplasia [29]. An indication
of the individual’s proximity to the positivity threshold
could be provided alongside strategies applying more in-
telligent use of FIT, such as varying the length of the
screening interval according to f-Hb, with those closest to
the threshold offered the opportunity to be screened more
regularly than those with very low or undetectable f-Hb.
Conclusions
With a growing interest in informed choice based on
levels of risk in screening programmes, our finding that
offering fully informed choice may not be feasible when
colonoscopy capacity is limited is applicable to CRC
screening programmes worldwide. However, the response
to the materials was very positive, suggesting that offering
risk information to those in the lowest and moderate risk
groups along with advice that it is not recommended that
they undergo colonoscopy at this time may be an option.
A further full-scale RCT would be required to examine
the actual uptake of colonoscopy in reality.
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